Form D · Other Health Care

MEDVENTIVE INC

Waltham, MA · CIK 0001376460

Offering snapshot reported Oct 21, 2011 · SEC filing

Reported sold
$12M
Offering amount: $12M
Investors reported
11
Form D · investor count
Minimum accepted
$11.6K
Reported outside-investor minimum
First sale
Sep 30, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 21, 2011Initial$12,000,000No comparison11SEC filing
Oct 21, 2011Initial$900,000No comparison9SEC filing
May 27, 2011Initial$1,500,000No comparison9SEC filing
Feb 18, 2010Amendment$10,000,000$5,142,500vs Jul 14, 20099SEC filing
Jan 13, 2010Amendment$9,000,000$4,142,500vs Jul 14, 20098SEC filing
Jul 14, 2009Initial$4,857,500No comparison6SEC filing
May 20, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Sep 22, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-167635
Series D Preferred Stock

Source: Form D, filed Oct 21, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Charles Baker Director
Nancy Brown Director, Executive
Mark Collins Executive
William R. Cowen Director
Peter Grua Director
Peter Gura Director
Nancy Ham Director, Executive
Mark Levine Director
Jonathan Niloff Director, Executive
Enrico Petrillo Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
400 Fifth Avenue Suite 200
Waltham, MA, 02451